Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin pharmacokinetics and skeletal muscle mass in head and neck cancer
NL-OMON23217Recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cisplatin in head and neck squamous cell carcinoma (HNSCC), sponsored by University Medical Center Utrecht. Started Jul 2018; status: recruiting.
02
Drugs
cisplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NL-OMON23217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23217.